Getting overwhelmed by the news is an everyday struggle for those wishing to stay in touch with the latest news. Our newsletter should make it easier for those interested in pharmacovigilance regulations, advancement in the relevant use of artificial intelligence, and personal growth. Approaching with care, the same as we provide PV services, we thoughtfully pick articles every month to keep you updated.
The Hong Kong University of Science and Technology has recently announced its development of four large language models for healthcare. A multitude of genes have been linked to the development of Alzheimer's disease. Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2024. And much more…
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2024
Scientific guidelines with summary-of-product-characteristics recommendations
New fee regulation: General questions and answers for all applicants
The Hong Kong University of Science and Technology has recently announced its development of four large language models for healthcare. WHAT IT'S ABOUT? Developed out of HKUST SuperPOD, the university's AI supercomputing facility, the LLM-based tools. In a statement to Healthcare IT News, the HKUST research team further shared details and findings from developing these models.
Dr. Anmol Kapoor, founder of CardiAI and BioAro, is an expert in precision healthcare, artificial intelligence and blockchain technologies. He has filed more than 70 patents in areas ranging from AI and genomics to quantum sciences and digital health. Through his work, he aims to transform modern healthcare through personalized, precision-based approaches.
If you fail to understand the fundamental nature of these tools, you’ll inevitably use them incorrectly.
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence the progression of neurodegeneration remains something of a black box though, in part because of the challenges of examining in molecular detail the brain of a living patient.
In 2018, the European Medicines Agency issued some risk minimisation measures related to unresolved adverse drug reactions (ADRs) reported for fluoroquinolones, including sensory ADRs. Spontaneous reporting databases frequently report unresolved outcomes for gustatory, olfactory and auditory (GOA) ADRs. However, such a high volume of unresolved GOA ADRs could reflect an under-investigated clinical issue or an intrinsic difficulty in the outcome assessment.
A new World Health Organization (WHO) study published today in eBioMedicine names 17 pathogens that regularly cause diseases in communities as top priorities for new vaccine development. The WHO study is the first global effort to systematically prioritize endemic pathogens based on criteria that included regional disease burden, antimicrobial resistance risk and socioeconomic impact.
Pictures used in this newsletter were generated by AI.